Victor W. Armstrong

12.4k total citations · 1 hit paper
239 papers, 9.8k citations indexed

About

Victor W. Armstrong is a scholar working on Transplantation, Molecular Biology and Surgery. According to data from OpenAlex, Victor W. Armstrong has authored 239 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Transplantation, 67 papers in Molecular Biology and 46 papers in Surgery. Recurrent topics in Victor W. Armstrong's work include Renal Transplantation Outcomes and Treatments (88 papers), Pharmacological Effects and Toxicity Studies (34 papers) and Biochemical and Molecular Research (29 papers). Victor W. Armstrong is often cited by papers focused on Renal Transplantation Outcomes and Treatments (88 papers), Pharmacological Effects and Toxicity Studies (34 papers) and Biochemical and Molecular Research (29 papers). Victor W. Armstrong collaborates with scholars based in Germany, United States and United Kingdom. Victor W. Armstrong's co-authors include Michael Oellerich, Maria Shipkova, Ekkehard Schütz, Eberhard Wieland, D. Seidel, Frank Streit, P. D. Niedmann, Nicolas von Ahsen, Lutz T. Weber and Burkhard Tönshoff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Victor W. Armstrong

235 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levels

1986 535 citations Victor W. Armstrong, D. Seidel et al. Atherosclerosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor W. Armstrong Germany	57	4.3k	2.5k	2.1k	2.1k	1.3k	239	9.8k
Michael Oellerich Germany	62	6.2k 1.4×	2.6k 1.0×	2.6k 1.2×	2.5k 1.2×	1.7k 1.3×	376	12.5k
Uwe Christians United States	51	3.6k 0.9×	2.8k 1.1×	2.5k 1.2×	2.3k 1.1×	683 0.5×	360	10.9k
Gilbert J. Burckart United States	43	2.4k 0.6×	1.7k 0.7×	2.6k 1.2×	922 0.4×	368 0.3×	255	7.4k
Ron H. N. van Schaik Netherlands	53	1.5k 0.3×	1.1k 0.4×	2.2k 1.0×	2.1k 1.0×	558 0.4×	242	9.3k
Piero Ruggenenti Italy	65	1.8k 0.4×	2.0k 0.8×	829 0.4×	1.5k 0.7×	376 0.3×	219	14.5k
Chul Woo Yang South Korea	47	1.9k 0.5×	2.2k 0.9×	569 0.3×	2.0k 1.0×	389 0.3×	526	9.8k
Anders Åsberg Norway	39	1.8k 0.4×	1.6k 0.6×	940 0.4×	462 0.2×	521 0.4×	251	5.9k
Eberhard Wieland Germany	38	1.8k 0.4×	911 0.4×	622 0.3×	1.2k 0.6×	486 0.4×	132	4.6k
Satohiro Masuda Japan	49	1.3k 0.3×	1.2k 0.5×	2.9k 1.4×	1.9k 0.9×	276 0.2×	191	8.8k
Erin G. Schuetz United States	77	1.4k 0.3×	1.6k 0.7×	4.0k 1.9×	4.7k 2.2×	424 0.3×	198	19.9k

Countries citing papers authored by Victor W. Armstrong

Since Specialization

Citations

This map shows the geographic impact of Victor W. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor W. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor W. Armstrong more than expected).

Fields of papers citing papers by Victor W. Armstrong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor W. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor W. Armstrong. The network helps show where Victor W. Armstrong may publish in the future.

Co-authorship network of co-authors of Victor W. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Victor W. Armstrong. A scholar is included among the top collaborators of Victor W. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor W. Armstrong. Victor W. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuchs, Christiane, Victor W. Armstrong, E. Quellhorst, & F. Scheler. (2015). Prophylaxis and Methods for Early Recognition of Aluminium Intoxication. Contributions to nephrology. 38. 81–91.

Gelder, Teun van, Hélio Tedesco‐Silva, Johan W. de Fijter, et al.. (2011). How Delayed Graft Function Impacts Exposure to Mycophenolic Acid in Patients After Renal Transplantation. Therapeutic Drug Monitoring. 33(2). 155–164. 12 indexed citations

Brandhorst, Gunnar, Franziska Brehmer, Oliver Groß, et al.. (2010). Mycophenolic Acid Predose Concentrations and Renal Function in a Mouse Model for Progressive Renal Fibrosis. Therapeutic Drug Monitoring. 32(1). 73–78. 9 indexed citations

Zibat, Arne, Anja Uhmann, Frauke Nitzki, et al.. (2009). Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts. Carcinogenesis. 30(6). 918–926. 35 indexed citations

Wallemacq, Pierre, Victor W. Armstrong, Merçè Brunet, et al.. (2009). Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference. Therapeutic Drug Monitoring. 31(2). 139–152. 362 indexed citations

Asif, Abdul R., et al.. (2006). Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie. 89(3). 393–402. 39 indexed citations

Flügge, Gabriele, Stephanie Plehm, Christina Schlumbohm, et al.. (2006). Differential expression of major histocompatibility complex class I molecules in the brain of a New World monkey, the common marmoset (Callithrix jacchus). Journal of Neuroimmunology. 176(1-2). 39–50. 21 indexed citations

Naesens, Maarten, Dirk Kuypers, Frank Streit, et al.. (2006). Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients. Clinical Pharmacology & Therapeutics. 80(5). 509–521. 60 indexed citations

Ahsen, Nicolas von, Victor W. Armstrong, Christoph Behrens, et al.. (2005). Association of Inosine Triphosphatase 94C>A and Thiopurine S-Methyltransferase Deficiency with Adverse Events and Study Drop-Outs under Azathioprine Therapy in a Prospective Crohn Disease Study. Clinical Chemistry. 51(12). 2282–2288. 75 indexed citations

10.

Armstrong, Victor W., Max Reinshagen, Nicolas von Ahsen, et al.. (2005). A Prospective Evaluation of the Association Between Adverse Drug Reactions to Azathioprine Therapy and Polymorphisms in the Gene Encoding Inosine Triphosphate Pyrophosphatase. Therapeutic Drug Monitoring. 27(2). 245–245. 1 indexed citations

11.

Kamdem, Landry K., Frank Streit, Ulrich M. Zanger, et al.. (2005). Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus. Clinical Chemistry. 51(8). 1374–1381. 180 indexed citations

12.

Shipkova, Maria, Srebrena Atanasova, P. D. Niedmann, et al.. (2003). Determination of Thiopurine Methyltransferase Phenotype in Isolated Human Erythrocytes Using a New Simple Nonradioactive HPLC Method. Therapeutic Drug Monitoring. 25(5). 637–644. 17 indexed citations

13.

Schettler, Volker, et al.. (2002). First Steps Toward the Establishment of a German Low‐Density Lipoprotein‐Apheresis Registry: Recommendations for the Indication and for Quality Management. Therapeutic Apheresis. 6(5). 381–383. 31 indexed citations

14.

Armstrong, Victor W.. (2002). Principles and Practice of Monitoring Immunosuppressive Drugs/Grundsätze und Praxis beim Monitoring von Immunsuppressiva. LaboratoriumsMedizin. 26(1-2). 27–36. 3 indexed citations

15.

Shipkova, Maria, Victor W. Armstrong, Dirk Kuypers, et al.. (2001). Effect of Cyclosporine Withdrawal on Mycophenolic Acid Pharmacokinetics in Kidney Transplant Recipients With Deteriorating Renal Function: Preliminary Report. Therapeutic Drug Monitoring. 23(6). 717–721. 65 indexed citations

16.

Shipkova, Maria, Victor W. Armstrong, Eberhard Wieland, et al.. (1999). Identification of glucoside and carboxyl‐linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. British Journal of Pharmacology. 126(5). 1075–1082. 175 indexed citations

17.

Zechner, Rudolf, et al.. (1992). Announcement. Atherosclerosis. 92(1). 87–87. 1 indexed citations

18.

Carlsson, J., Victor W. Armstrong, Hansotto Reiber, K. Felgenhauer, & D. Seidel. (1991). Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clinica Chimica Acta. 196(2-3). 167–176. 80 indexed citations

19.

Eisenhauer, T., Victor W. Armstrong, P. Schuff‐Werner, et al.. (1989). Long-term Clinical Experience with HELP-LDL-Apheresis in Combination with HMG-CoA-Reductase Inhibitors for Maximum Treatment of Coronary Heart Disease Associated with Severe Hypercholesterolemia. ASAIO Transactions. 35(3). 580–582. 6 indexed citations

20.

Armstrong, Victor W., et al.. (1988). Acute and long-term effects of low-density lipoprotein apheresis on the serum concentrations of vitamins E and A. Journal of Molecular Medicine. 66(3). 123–128. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact